Clin2
NCT07520305Worth exploringNot yet recruiting

Probiotic supplement for newly diagnosed type 2 diabetes

Type 2 Diabetes

Part of Hormones & metabolism clinical trials.

This study tests whether a specific beneficial bacteria supplement (called Lactobacillus paracasei LC19) can help control blood sugar in people with newly diagnosed type 2 diabetes. It may offer an option to manage diabetes without starting medication right away.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
70 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • Between 18 and 65 years old.
  • Recently diagnosed with type 2 diabetes and have never taken any diabetes medicine.
  • HbA1c (a blood sugar marker) between 7.0% and 9.0%.
  • No serious heart, liver, kidney, thyroid problems, or cancer.
  • No certain medicines (like antibiotics or steroids) or probiotics in the past 3 months.
  • Not pregnant or planning pregnancy during the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06704022Not yet recruiting· Phase 1
Gut microbiome changes from a nutritional supplement in type 2 diabetes

This trial tests how a special oral nutritional supplement affects the gut microbiome (the bacteria in your digestive system) in people with type 2 diabetes. You will swallow a small capsule that collects samples as it travels through your gut, helping researchers understand the changes.

Calgary, Alberta
NCT07464691Not yet recruiting
Prebiotic supplement for blood sugar control in type 2 diabetes

This study is testing whether a daily prebiotic supplement (a type of fiber that feeds good gut bacteria) can help improve blood sugar control in adults with type 2 diabetes. It is for Saudi adults between 45 and 60 years old who have had diabetes for several years.

Riyadh
NCT06847178Not yet recruiting· Phase 2/Phase 3
Study of LC-Z300-01 for adults with type 2 diabetes

This study tests a new medicine called LC-Z300-01 to see if it is safe and works well for people with type 2 diabetes. It may help lower blood sugar levels.

Shanghai, Shanghai Municipality
NCT07622628Recruiting
AI-Guided Microbiome Nutrition for Better Blood Sugar Control

This trial tests whether a personalized nutrition plan based on your gut bacteria (microbiome) can help improve blood sugar control in type 2 diabetes. Researchers will use artificial intelligence to match you with a diet tailored to your unique gut bacteria.

Izmir
NCT06384313Recruiting
Butyrate supplement for preventing diabetes

This study tests if a special type of fat (butyrate) can help prevent diabetes in people who are overweight and have early signs of blood sugar problems. You would take a supplement for several weeks to see if it improves how your body handles sugar.

Maastricht, Limburg
NCT07606066Recruiting
Finding Type 2 Diabetes Patients for Future Research Studies

This is a screening study to identify and understand people with type 2 diabetes whose blood sugar isn't well controlled, so they can potentially join future diabetes research trials. You won't receive a new treatment in this study—it's about getting to know your health history and seeing if you might be a good fit for upcoming studies.

Peoria, Arizona

Hear when a new Type 2 diabetes trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.